KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Halozyme Therapeutics (HALO) Tax Rate (2016 - 2025)

Halozyme Therapeutics (HALO) has disclosed Tax Rate for 10 consecutive years, with 40.43% as the latest value for Q4 2025.

  • On a quarterly basis, Tax Rate fell 6355.0% to 40.43% in Q4 2025 year-over-year; TTM through Dec 2025 was 32.13%, a 1184.0% increase, with the full-year FY2025 number at 32.13%, up 1184.0% from a year prior.
  • Tax Rate was 40.43% for Q4 2025 at Halozyme Therapeutics, down from 19.96% in the prior quarter.
  • In the past five years, Tax Rate ranged from a high of 208.08% in Q3 2021 to a low of 40.43% in Q4 2025.
  • A 5-year average of 22.12% and a median of 19.32% in 2025 define the central range for Tax Rate.
  • Peak YoY movement for Tax Rate: soared 20791bps in 2021, then tumbled -19170bps in 2022.
  • Halozyme Therapeutics' Tax Rate stood at 21.82% in 2021, then soared by 185bps to 18.49% in 2022, then decreased by -16bps to 15.61% in 2023, then surged by 48bps to 23.12% in 2024, then tumbled by -275bps to 40.43% in 2025.
  • Per Business Quant, the three most recent readings for HALO's Tax Rate are 40.43% (Q4 2025), 19.96% (Q3 2025), and 19.43% (Q2 2025).